Weekly News, Events, and Insights from the Healthcare 3D Printing and Bioprinting Sector
The Lattice is 3DHEALS weekly recap of the latest developments, expert insights, upcoming events in the world of healthcare 3D printing. Have a cool 3D printed Lattice photo to share with us? Send to: [email protected]
About this week’s Lattice Photo: Architect Bruno Juričić has unveiled one of the world’s largest and most complex 3D-printed structures at the 16th Venice Architecture Biennale. Dubbed the Cloud Pergola / The Architecture of Hospitality, this massive, site-specific structure for the Croatian Pavilion features 300 kilograms of 3D-printed biodegradable plastic. The immersive cloud-like installation invites visitors to reflect on the topics of hospitality, climate change, and sociability. (Link)
Last week I made it to RAPID+TCT (and Detroit) for the first time in my life. Practically everyone in 3D printing made an appearance. I had the pleasure of meeting many 3DHEALS community managers from all over the world in person, hear their stories and ambitions, and continued our previous conversations ranging from segmentation of medical images to workforce development. Thanks to our Detroit community manager Richard Doerer, more than 70 people from healthcare 3D printing space showed up for HP at the RAPID conferencing, connecting people both in and outside of Detroit. The three key takeaways from FDA, reimbursement, and decentralized care are summarized here…
In my previous posts, I discussed how the transition that we’re observing to digital manufacturing (especially additive manufacturing) means medical device manufacturers are confronted with a new set of risks related to the management and control of the engineering and manufacturing data of their products. I identified five key risk areas that manufacturers must secure in order to safeguard their brand value — I discussed IP risk, liability risk, and confidentiality risk in my last post. In this final post, I’ll focus on two risk areas that are specifically focused on the manufacturing process: production risk and traceability risk…
The “Expert Corner” blogs aim to provide 3DHEALS readers unfiltered first-person narratives from industry experts and entrepreneurs in healthcare 3D printing and bioprinting fields. Zero-degree of separation is what we want to achieve between the cutting-edge technology and 3DHEALS community. Submit your story here.
Kimberly Homan, Ph.D. just moved from being a Research Associate at the Wyss Institute for Biologically Inspired Engineering at Harvard to a position in a stealth-mode startup company. Previously, she attended the University of Texas at Austin where she earned a Ph.D. in biomedical engineering. While in Austin, Texas she started a company based on the biomedical imaging contrast agents she developed in her graduate work. Her company, NanoHybrids Inc, is still based in Austin and has brought several lines of unique gold nanoparticles to market. Kimberly then applied her biomedical engineering expertise to tissue engineering and worked for the last 6 years to use 3D bioprinting to create functional living tissues. In the laboratory of Jennifer Lewis at Harvard University in Wyss and in collaboration with Annie Moisan at Roche, she built kidney tissue on perfusable chips that can be used for drug screening, mechanistic safety, and ultimately, regenerative medicine.She will be a speaker at our upcoming annual summer event in Boston. (Read Interview)
There is nothing more exciting than meeting people with shared vision and challenges. Within last two weeks, we welcomed four new global community managers, including William Harley (Melbourne, Australia), Prashanth Ray (Nagpur, India), Jim Long (North Carolina, US), Shashank Misra (Mumbai, India).